arrow
Y

Yan Song

analysis group
H指数:25
被引数:2,340

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Healthcare resource utilization and cost of invasive pneumococcal disease, pneumonia, and acute otitis media in commercially and medicaid-insured children by risk group in the United States, 2018 to 2023

2018至2023年美国商业保险和医疗补助计划参保儿童中,按风险组划分的侵袭性肺炎球菌病、肺炎和急性中耳炎的医疗资源利用及费用

2026-09-050
OAAI
Real-World Clinical Outcomes and Biopsy Patterns of Older Patients with Unresected Non-Small-Cell Lung Cancer Treated with Primary Stereotactic Body Radiotherapy

老年不可切除非小细胞肺癌患者接受原发性立体定向体放射治疗的真实世界临床结局及活检模式

2025-12-050
OAAI
Treatment Patterns, Disease Recurrence, and Overall Survival in Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy: A Population-Level Claims-Based Analysis

Squires, P.; Cook, E.E.; Song, Y.; Wang, C.-Y.; Zhang, A.; Seshasayee, S.M.; Rogiers, A.; Li, H.; Mamtani, R. 肌肉浸润性膀胱癌患者在根治性膀胱切除术后:治疗模式、疾病复发与总生存期——一项基于人群索赔数据的分析。Clin. Genitourin. Cancer 2026, 24, 102466. [Google Scholar] [CrossRef]

2025-12-010
PRE
Corrigendum to “PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S.” [Oral Oncol. 161 (2025) 107146]

勘误:“PD-L1 testing patterns in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the U.S.” [Oral Oncol. 161 (2025) 107146]

2025-04-110
PRE
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis

老年早期HER2-Negative乳腺癌患者无病生存终点与总生存期的相关性: SEER-Medicare分析

2024-12-160
OAAI
Efficacy and Safety of Carfilzomib-Based Regiments for the Treatment of Relapsed or Refractory Multiple Myeloma: Single-Center Real-Word Data

卡非佐米(Carfilzomib)为基础方案治疗复发或难治性多发性骨髓瘤的疗效与安全性:单中心真实世界数据

BLOOD
IF23.1
2024-11-050
PRE